Novadiol Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Conv. Debt
  • Latest Deal Amount
  • $1.09M
Latest Deal Amount

Novadiol General Information

Description

Developer of pharmaceuticals for treatment of vitamin D deficiency. The company specializes in developing medicines for the treatment of vitamin D deficiency and for secondary Hyperparathyroidism.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 6425 Nieman
  • Shawnee, KS 66203
  • United States
+1 (913) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novadiol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Convertible Debt 03-Jul-2014 $1.09M 00.000 Completed Startup
To view Novadiol’s complete valuation and funding history, request access »

Novadiol Executive Team (3)

Name Title Board Seat Contact Info
GP Georges Founder & Chief Executive Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Novadiol Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial